SOPHiA GENETICS (SOPH) News Today $2.87 -0.03 (-1.03%) Closing price 04:00 PM EasternExtended Trading$2.88 +0.01 (+0.35%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SOPH Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period High Court grants custody of IVF baby to adoptive, not biological parentsMay 12, 2025 | msn.comSOPHiA GENETICS First Quarter 2025 Earnings: Revenues Beat Expectations, EPS LagsMay 12, 2025 | uk.finance.yahoo.comSupreme Court upholds decision to keep IVF child with birth mother following embryo mix-upMay 12, 2025 | msn.comSupreme Court rules birth parents of child born in IVF mix-up are legal parentsMay 12, 2025 | msn.comSOPHiA GENETICS SA (SOPH) Q1 2025 Earnings Call TranscriptMay 10, 2025 | seekingalpha.comSOPHiA GENETICS (NASDAQ:SOPH) Releases Earnings Results, Misses Expectations By $0.05 EPSSOPHiA GENETICS (NASDAQ:SOPH - Get Free Report) released its earnings results on Tuesday. The company reported ($0.26) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.21) by ($0.05). SOPHiA GENETICS had a negative net margin of 110.71% and a negative return on equity of 55.06%.May 8, 2025 | marketbeat.comSophia Genetics SA (SOPH) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Improved ...May 7, 2025 | finance.yahoo.comSOPHiA GENETICS Reports First Quarter 2025 ResultsMay 6, 2025 | prnewswire.comSOPHiA GENETICS (SOPH) Projected to Post Earnings on TuesdaySOPHiA GENETICS (NASDAQ:SOPH) will be releasing its Q1 2025 earnings before the market opens on Tuesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-6-sophia-genetics-sa-stock/)May 1, 2025 | marketbeat.comSOPHiA GENETICS expands AstraZeneca liquid biopsy testApril 30, 2025 | investing.comSOPHiA GENETICS Expands AstraZeneca Partnership to Advance Liquid Biopsy WorldwideApril 29, 2025 | msn.comSOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACRApril 28, 2025 | prnewswire.comSOPHiA GENETICS to Announce Financial Results for First Quarter 2025 on May 6, 2025April 22, 2025 | prnewswire.comSophia Genetics, Precision for Medicine enter strategic partnershipApril 9, 2025 | markets.businessinsider.comPrecision for Medicine Partners with SOPHiA GENETICS to Expand Biopharma Services with the SOPHiA DDM™ Platform and its Liquid Biopsy CapabilitiesApril 8, 2025 | prnewswire.comSOPHiA GENETICS SA (NASDAQ:SOPH) Short Interest UpdateSOPHiA GENETICS SA (NASDAQ:SOPH - Get Free Report) was the recipient of a significant decrease in short interest in March. As of March 15th, there was short interest totalling 48,500 shares, a decrease of 21.5% from the February 28th total of 61,800 shares. Based on an average trading volume of 75,800 shares, the days-to-cover ratio is presently 0.6 days. Approximately 0.1% of the shares of the stock are short sold.April 1, 2025 | marketbeat.comMorgan Stanley Keeps Their Hold Rating on SOPHiA GENETICS (SOPH)March 20, 2025 | markets.businessinsider.comSOPHiA GENETICS (SOPH) Gets a Buy from BTIGMarch 18, 2025 | markets.businessinsider.comSOPHiA GENETICS Announces Two Million Patient Cases Analyzed, Marking a New Milestone for Data-Driven Medicine at NVIDIA GTCMarch 18, 2025 | prnewswire.comShort Interest in SOPHiA GENETICS SA (NASDAQ:SOPH) Grows By 64.4%SOPHiA GENETICS SA (NASDAQ:SOPH - Get Free Report) was the recipient of a significant growth in short interest in February. As of February 28th, there was short interest totalling 61,800 shares, a growth of 64.4% from the February 13th total of 37,600 shares. Based on an average daily volume of 74,500 shares, the short-interest ratio is currently 0.8 days. Approximately 0.1% of the shares of the company are short sold.March 16, 2025 | marketbeat.comSOPHiA GENETICS (SOPH) Receives a Buy from BTIGMarch 12, 2025 | markets.businessinsider.comBaby Sophia from embryo swap will stay with birth parents court rules on appealMarch 11, 2025 | msn.comDistrict Court rules to keep IVF child with birth mother following embryo mix-upMarch 10, 2025 | msn.comCourt overturns ruling that ordered toddler returned to genetic parents following embryo mix-upMarch 10, 2025 | msn.comSophia Genetics price target lowered to $5 from $6 at BTIGMarch 6, 2025 | markets.businessinsider.comSOPHiA GENETICS (SOPH) Gets a Buy from RBC CapitalMarch 5, 2025 | markets.businessinsider.comSOPHiA GENETICS SA (NASDAQ:SOPH) Q4 2024 Earnings Call TranscriptMarch 5, 2025 | msn.comSOPHiA GENETICS Full Year 2024 Earnings: In Line With ExpectationsMarch 5, 2025 | finance.yahoo.comSOPHiA GENETICS SA (SOPH) Q4 2024 Earnings Call TranscriptMarch 4, 2025 | seekingalpha.comSophia Genetics sees FY25 revenue $72M-$76M, consensus $74.51MMarch 4, 2025 | markets.businessinsider.comCraig-Hallum Sticks to Its Buy Rating for SOPHiA GENETICS (SOPH)March 4, 2025 | markets.businessinsider.comSOPHiA GENETICS (NASDAQ:SOPH) Issues Earnings ResultsSOPHiA GENETICS (NASDAQ:SOPH - Get Free Report) announced its quarterly earnings results on Tuesday. The company reported ($0.23) EPS for the quarter, meeting the consensus estimate of ($0.23). SOPHiA GENETICS had a negative return on equity of 55.06% and a negative net margin of 110.71%.March 4, 2025 | marketbeat.comSOPHiA GENETICS Reports Fourth Quarter and Full Year 2024 ResultsMarch 4, 2025 | prnewswire.comSOPHiA GENETICS SA (NASDAQ:SOPH) Sees Large Growth in Short InterestSOPHiA GENETICS SA (NASDAQ:SOPH - Get Free Report) saw a significant increase in short interest during the month of February. As of February 15th, there was short interest totalling 37,600 shares, an increase of 89.9% from the January 31st total of 19,800 shares. Currently, 0.1% of the shares of the company are short sold. Based on an average daily volume of 69,500 shares, the days-to-cover ratio is presently 0.5 days.March 2, 2025 | marketbeat.comSOPHiA GENETICS: Leading Healthcare Institutions Adopt MSK-ACCESS for Liquid Biopsy TestingFebruary 24, 2025 | finanznachrichten.deSophia Genetics announces adoption of MSK-AccessFebruary 24, 2025 | markets.businessinsider.comLeading Healthcare Institutions Adopt MSK-ACCESS® for Liquid Biopsy TestingFebruary 24, 2025 | prnewswire.comSOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2024 on March 4, 2025February 18, 2025 | prnewswire.comSOPHiA GENETICS SA (NASDAQ:SOPH) Sees Large Drop in Short InterestSOPHiA GENETICS SA (NASDAQ:SOPH - Get Free Report) was the recipient of a large drop in short interest in the month of January. As of January 31st, there was short interest totalling 19,800 shares, a drop of 34.0% from the January 15th total of 30,000 shares. Approximately 0.0% of the company's shares are short sold. Based on an average daily volume of 53,500 shares, the short-interest ratio is currently 0.4 days.February 15, 2025 | marketbeat.comOne-year-old's rare disorder which leaves her always 'starving'February 15, 2025 | uk.news.yahoo.comWhat a $2 Million Per Dose Gene Therapy Reveals About Drug PricingFebruary 13, 2025 | msn.comSOPHiA GENETICS (NASDAQ:SOPH) Shares Down 4.4% - Here's WhySOPHiA GENETICS (NASDAQ:SOPH) Trading Down 4.4% - Here's WhyFebruary 12, 2025 | marketbeat.comRBC Capital Sticks to Their Buy Rating for SOPHiA GENETICS (SOPH)February 6, 2025 | markets.businessinsider.comSOPHiA GENETICS Launches Comprehensive MRD Tracking CapabilitiesJanuary 28, 2025 | prnewswire.comHealthcare Analytics Industry to Hit USD 133.1 billion by 2029 with 24.3% CAGR | MarketsandMarkets™January 21, 2025 | finance.yahoo.comCancer Biopsy Market Size is Expected to Reach USD 60.92 Billion by 2033, Growing at a CAGR of 7.81%: Straits ResearchJanuary 20, 2025 | finance.yahoo.comShort Interest in SOPHiA GENETICS SA (NASDAQ:SOPH) Decreases By 15.1%SOPHiA GENETICS SA (NASDAQ:SOPH - Get Free Report) saw a large decrease in short interest in the month of December. As of December 31st, there was short interest totalling 31,400 shares, a decrease of 15.1% from the December 15th total of 37,000 shares. Based on an average daily trading volume, of 25,600 shares, the short-interest ratio is presently 1.2 days. Currently, 0.1% of the shares of the stock are short sold.January 16, 2025 | marketbeat.comMorgan Stanley Reaffirms Their Hold Rating on SOPHiA GENETICS (SOPH)January 14, 2025 | markets.businessinsider.comShort Interest in SOPHiA GENETICS SA (NASDAQ:SOPH) Grows By 38.6%SOPHiA GENETICS SA (NASDAQ:SOPH - Get Free Report) was the recipient of a significant growth in short interest during the month of December. As of December 15th, there was short interest totalling 37,000 shares, a growth of 38.6% from the November 30th total of 26,700 shares. Based on an average daily volume of 24,300 shares, the days-to-cover ratio is currently 1.5 days. Currently, 0.1% of the company's stock are short sold.December 29, 2024 | marketbeat.comCraig-Hallum Initiates Coverage of SOPHiA GENETICS (SOPH) with Buy RecommendationDecember 19, 2024 | msn.com Get SOPHiA GENETICS News Delivered to You Automatically Sign up to receive the latest news and ratings for SOPH and its competitors with MarketBeat's FREE daily newsletter. Email Address SOPH Media Mentions By Week SOPH Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SOPH News Sentiment▼1.871.03▲Average Medical News Sentiment SOPH News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SOPH Articles This Week▼22▲SOPH Articles Average Week Get SOPHiA GENETICS News Delivered to You Automatically Sign up to receive the latest news and ratings for SOPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies OCS News NUVB News XERS News PRAX News AKBA News NRIX News AVXL News IMNM News RCKT News AVBP News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SOPH) was last updated on 5/28/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredBanks aren’t ready for this altcoin—are you?I've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredTrump Quietly Planning $15 Trillion Crypto ShockerMost investors are still unaware, but I believe a new White House action may have quietly opened the floodgate...Paradigm Press | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored“You all just got a lot richer”Trump Knows What He’s Doing. When the president says he’s going to let RFK “go wild” … and Big Pharma crash...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SOPHiA GENETICS SA Please log in to your account or sign up in order to add this asset to your watchlist. Share SOPHiA GENETICS With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SOPH Stock Free SOPH Stock Alerts